Alongside our long-standing obsession with artisanally crafted cuisine rests a similar fixation on elevated cocktails crafted ...

Tempus AI continued to see dramatic revenue and gross profit growth in the first quarter, with year-over-year revenue up 75.4 ...

Shares of Tempus AI (NASDAQ: TEM) were skyrocketing 16.5% higher as of 10:39 a.m. ET on Wednesday. The big gain came after the healthcare artificial intelligence (AI) company announced a multiyear ...

One big advantage? Tempus has one of the largest molecular libraries of cancer data. That puts it in a strong position to lead the charge in AI-powered healthcare analytics. The company's also ...

CHICAGO (AP) — CHICAGO (AP) — Tempus AI Inc. (TEM) on Tuesday reported a loss of $68 million in its first quarter. On a per-share basis, the Chicago-based company said it had a loss of 40 cents.

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Tempus Ai wasn’t one of them. The 10 stocks that made the cut ...

Don’t miss this list of 10 overlooked stocks—including one paying a 9% dividend—before Wall Street catches on. On Tuesday, Tempus AI reported first-quarter revenue of $255.74 million ...

The Chicago-based startup formed in 2020 by Tempus AI executives Ryan Fukushima and Eric Lefkofsky is using an artificial intelligence platform, PathOS, to develop drugs, primarily in the oncology ...

Tempus enters earnings with strong tailwinds but elevated scrutiny. The stock has surged over 80% in the past six months, and analysts have maintained tight but bullish targets — averaging $61. ...

Get our list of 10 overlooked stocks—including one paying a 9% dividend—before Wall Street catches on. Tempus AI Inc TEM reported first-quarter financial results Tuesday after the market close.

What you find is a company with true platform potential, one that balances high fixed-cost complexity and operating leverage. The foundation of Tempus' upside is not only revenue acceleration ...